MRK logo

Merck & Co (MRK) Revenue

Annual revenue:

$64.17B+$4.05B(+6.74%)
December 31, 2024

Summary

  • As of today (April 24, 2025), MRK annual revenue is $64.17 billion, with the most recent change of +$4.05 billion (+6.74%) on December 31, 2024.
  • During the last 3 years, MRK annual revenue has risen by +$15.46 billion (+31.75%).
  • MRK annual revenue is now at all-time high.

Performance

MRK Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKincome statement metrics

Quarterly revenue:

$15.62B-$1.03B(-6.20%)
December 31, 2024

Summary

  • As of today (April 24, 2025), MRK quarterly revenue is $15.62 billion, with the most recent change of -$1.03 billion (-6.20%) on December 31, 2024.
  • Over the past year, MRK quarterly revenue has dropped by -$1.03 billion (-6.20%).
  • MRK quarterly revenue is now -6.20% below its all-time high of $16.66 billion, reached on September 30, 2024.

Performance

MRK Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKincome statement metrics

TTM revenue:

$64.17B+$994.00M(+1.57%)
December 31, 2024

Summary

  • As of today (April 24, 2025), MRK TTM revenue is $64.17 billion, with the most recent change of +$994.00 million (+1.57%) on December 31, 2024.
  • Over the past year, MRK TTM revenue has increased by +$994.00 million (+1.57%).
  • MRK TTM revenue is now at all-time high.

Performance

MRK TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMRKincome statement metrics

MRK Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.7%-6.2%+1.6%
3 y3 years+31.8%-6.2%+1.6%
5 y5 years+64.0%-6.2%+1.6%

MRK Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+31.8%-6.2%+13.0%at high+18.9%
5 y5-yearat high+64.0%-6.2%+67.0%at high+75.9%
alltimeall timeat high+1708.8%-6.2%+211.9%at high+7461.6%

Merck & Co Revenue History

DateAnnualQuarterlyTTM
Dec 2024
$64.17B(+6.7%)
$15.62B(-6.2%)
$64.17B(+1.6%)
Sep 2024
-
$16.66B(+3.4%)
$63.17B(+1.1%)
Jun 2024
-
$16.11B(+2.1%)
$62.48B(+1.8%)
Mar 2024
-
$15.78B(+7.8%)
$61.40B(+2.1%)
Dec 2023
$60.12B(+1.4%)
$14.63B(-8.3%)
$60.11B(+1.3%)
Sep 2023
-
$15.96B(+6.2%)
$59.31B(+1.7%)
Jun 2023
-
$15.04B(+3.8%)
$58.31B(+0.8%)
Mar 2023
-
$14.49B(+4.8%)
$57.87B(-2.4%)
Dec 2022
$59.28B(+21.7%)
$13.83B(-7.5%)
$59.28B(+0.5%)
Sep 2022
-
$14.96B(+2.5%)
$58.97B(+3.2%)
Jun 2022
-
$14.59B(-8.2%)
$57.17B(+5.9%)
Mar 2022
-
$15.90B(+17.6%)
$53.98B(+10.8%)
Dec 2021
$48.70B(+17.3%)
$13.52B(+2.8%)
$48.70B(+5.6%)
Sep 2021
-
$13.15B(+15.4%)
$46.13B(+5.1%)
Jun 2021
-
$11.40B(+7.3%)
$43.91B(+4.9%)
Mar 2021
-
$10.63B(-2.9%)
$41.86B(-3.3%)
Dec 2020
$41.52B(+6.1%)
$10.95B(+0.2%)
$43.29B(+18.6%)
Sep 2020
-
$10.93B(+16.9%)
$36.49B(-3.9%)
Jun 2020
-
$9.35B(-22.4%)
$37.96B(-6.0%)
Mar 2020
-
$12.06B(+190.6%)
$40.36B(+3.2%)
Dec 2019
$39.12B(-7.5%)
$4.15B(-66.5%)
$39.12B(-14.9%)
Sep 2019
-
$12.40B(+5.4%)
$45.97B(+3.6%)
Jun 2019
-
$11.76B(+8.7%)
$44.37B(+3.0%)
Mar 2019
-
$10.82B(-1.7%)
$43.07B(+1.8%)
Dec 2018
$42.29B(+5.4%)
$11.00B(+1.9%)
$42.29B(+1.4%)
Sep 2018
-
$10.79B(+3.1%)
$41.73B(+1.1%)
Jun 2018
-
$10.46B(+4.3%)
$41.26B(+1.3%)
Mar 2018
-
$10.04B(-3.8%)
$40.73B(+1.5%)
Dec 2017
$40.12B(+0.8%)
$10.43B(+1.0%)
$40.12B(+0.8%)
Sep 2017
-
$10.32B(+4.0%)
$39.80B(-0.5%)
Jun 2017
-
$9.93B(+5.3%)
$40.02B(+0.2%)
Mar 2017
-
$9.43B(-6.7%)
$39.93B(+0.3%)
Dec 2016
$39.81B(+0.8%)
$10.12B(-4.0%)
$39.81B(-0.3%)
Sep 2016
-
$10.54B(+7.0%)
$39.91B(+1.2%)
Jun 2016
-
$9.84B(+5.7%)
$39.44B(+0.1%)
Mar 2016
-
$9.31B(-8.8%)
$39.38B(-0.3%)
Dec 2015
$39.50B(-6.5%)
$10.21B(+1.4%)
$39.50B(-0.7%)
Sep 2015
-
$10.07B(+2.9%)
$39.77B(-1.2%)
Jun 2015
-
$9.79B(+3.8%)
$40.25B(-2.8%)
Mar 2015
-
$9.43B(-10.1%)
$41.40B(-2.0%)
Dec 2014
$42.24B(-4.1%)
$10.48B(-0.7%)
$42.24B(-1.9%)
Sep 2014
-
$10.56B(-3.4%)
$43.08B(-1.1%)
Jun 2014
-
$10.93B(+6.5%)
$43.55B(-0.2%)
Mar 2014
-
$10.26B(-9.3%)
$43.63B(-0.9%)
Dec 2013
$44.03B(-6.8%)
$11.32B(+2.6%)
$44.03B(-0.9%)
Sep 2013
-
$11.03B(+0.2%)
$44.45B(-1.0%)
Jun 2013
-
$11.01B(+3.2%)
$44.91B(-2.8%)
Mar 2013
-
$10.67B(-9.1%)
$46.21B(-2.2%)
Dec 2012
$47.27B(-1.6%)
$11.74B(+2.2%)
$47.27B(-1.2%)
Sep 2012
-
$11.49B(-6.7%)
$47.82B(-1.1%)
Jun 2012
-
$12.31B(+4.9%)
$48.36B(+0.3%)
Mar 2012
-
$11.73B(-4.6%)
$48.20B(+0.3%)
Dec 2011
$48.05B(+4.5%)
$12.29B(+2.3%)
$48.05B(+0.4%)
Sep 2011
-
$12.02B(-1.1%)
$47.85B(+1.9%)
Jun 2011
-
$12.15B(+4.9%)
$46.95B(+1.7%)
Mar 2011
-
$11.58B(-4.3%)
$46.15B(+0.3%)
Dec 2010
$45.99B(+67.7%)
$12.09B(+8.7%)
$45.99B(+4.5%)
Sep 2010
-
$11.13B(-1.9%)
$43.99B(+13.0%)
Jun 2010
-
$11.35B(-0.7%)
$38.91B(+16.3%)
Mar 2010
-
$11.42B(+13.2%)
$33.46B(+22.0%)
Dec 2009
$27.43B(+15.0%)
$10.09B(+66.8%)
$27.43B(+17.4%)
Sep 2009
-
$6.05B(+2.5%)
$23.37B(+0.5%)
Jun 2009
-
$5.90B(+9.6%)
$23.26B(-0.6%)
Mar 2009
-
$5.39B(-10.7%)
$23.41B(-1.8%)
Dec 2008
$23.85B(-1.4%)
$6.03B(+1.5%)
$23.85B(-0.9%)
Sep 2008
-
$5.94B(-1.8%)
$24.06B(-0.5%)
Jun 2008
-
$6.05B(+3.9%)
$24.19B(-0.2%)
Mar 2008
-
$5.82B(-6.7%)
$24.25B(+0.2%)
Dec 2007
$24.20B(+6.9%)
$6.24B(+2.8%)
$24.20B(+0.8%)
Sep 2007
-
$6.07B(-0.6%)
$24.00B(+2.8%)
Jun 2007
-
$6.11B(+5.9%)
$23.34B(+1.5%)
Mar 2007
-
$5.77B(-4.5%)
$23.00B(+1.6%)
Dec 2006
$22.64B(+2.8%)
$6.04B(+11.7%)
$22.64B(+1.2%)
Sep 2006
-
$5.41B(-6.3%)
$22.36B(-0.0%)
Jun 2006
-
$5.77B(+6.7%)
$22.36B(+1.4%)
Mar 2006
-
$5.41B(-6.2%)
$22.06B(+0.2%)
Dec 2005
$22.01B(-4.2%)
$5.77B(+6.5%)
$22.01B(-0.1%)
Sep 2005
-
$5.42B(-0.9%)
$22.03B(-0.6%)
Jun 2005
-
$5.47B(+2.0%)
$22.15B(-2.4%)
Mar 2005
-
$5.36B(-7.3%)
$22.70B(-1.2%)
Dec 2004
$22.97B
$5.78B(+4.4%)
$22.97B(+0.7%)
Sep 2004
-
$5.54B(-8.0%)
$22.82B(-1.0%)
DateAnnualQuarterlyTTM
Jun 2004
-
$6.02B(+6.9%)
$23.04B(+2.2%)
Mar 2004
-
$5.63B(+0.1%)
$22.55B(+0.3%)
Dec 2003
$22.49B(+4.8%)
$5.63B(-2.3%)
$22.49B(-1.9%)
Sep 2003
-
$5.76B(+4.3%)
$22.92B(+1.5%)
Jun 2003
-
$5.53B(-0.8%)
$22.58B(-24.4%)
Mar 2003
-
$5.57B(-8.0%)
$29.86B(-18.1%)
Dec 2002
$21.45B(+1.2%)
$6.06B(+11.6%)
$36.46B(+121.7%)
Sep 2002
-
$5.43B(-57.6%)
$16.45B(-28.3%)
Jun 2002
-
$12.81B(+5.3%)
$22.94B(+4.2%)
Mar 2002
-
$12.17B(-187.2%)
$22.02B(+3.9%)
Dec 2001
$21.20B(-47.5%)
-$13.96B(-217.1%)
$21.20B(-54.5%)
Sep 2001
-
$11.92B(+0.2%)
$46.63B(+3.0%)
Jun 2001
-
$11.89B(+4.8%)
$45.27B(+5.6%)
Mar 2001
-
$11.35B(-1.1%)
$42.86B(+6.2%)
Dec 2000
$40.36B(+23.4%)
$11.47B(+8.5%)
$40.36B(+6.6%)
Sep 2000
-
$10.57B(+11.5%)
$37.86B(+6.7%)
Jun 2000
-
$9.48B(+7.1%)
$35.49B(+4.3%)
Mar 2000
-
$8.85B(-1.2%)
$34.03B(+4.0%)
Dec 1999
$32.71B(+21.6%)
$8.96B(+9.4%)
$32.71B(+4.6%)
Sep 1999
-
$8.20B(+2.2%)
$31.28B(+4.5%)
Jun 1999
-
$8.02B(+6.4%)
$29.92B(+5.5%)
Mar 1999
-
$7.54B(+0.1%)
$28.38B(+5.5%)
Dec 1998
$26.90B(+13.8%)
$7.53B(+10.1%)
$26.90B(+5.1%)
Sep 1998
-
$6.84B(+5.7%)
$25.60B(+3.7%)
Jun 1998
-
$6.47B(+6.8%)
$24.69B(+2.3%)
Mar 1998
-
$6.06B(-2.8%)
$24.13B(+2.1%)
Dec 1997
$23.64B(+19.2%)
$6.23B(+5.1%)
$23.64B(+3.6%)
Sep 1997
-
$5.93B(+0.3%)
$22.81B(+4.3%)
Jun 1997
-
$5.91B(+6.1%)
$21.87B(+4.8%)
Mar 1997
-
$5.57B(+3.0%)
$20.87B(+5.2%)
Dec 1996
$19.83B(+18.9%)
$5.41B(+8.5%)
$19.83B(+4.5%)
Sep 1996
-
$4.98B(+1.5%)
$18.98B(+4.5%)
Jun 1996
-
$4.91B(+8.4%)
$18.17B(+4.4%)
Mar 1996
-
$4.53B(-0.6%)
$17.39B(+4.3%)
Dec 1995
$16.68B(+11.4%)
$4.56B(+9.3%)
$16.68B(+4.3%)
Sep 1995
-
$4.17B(+0.9%)
$16.00B(+2.4%)
Jun 1995
-
$4.14B(+8.3%)
$15.62B(+2.3%)
Mar 1995
-
$3.82B(-1.4%)
$15.27B(+2.0%)
Dec 1994
$14.97B(+42.6%)
$3.87B(+2.1%)
$14.97B(+6.2%)
Sep 1994
-
$3.79B(0.0%)
$14.10B(+9.7%)
Jun 1994
-
$3.79B(+7.9%)
$12.85B(+10.5%)
Mar 1994
-
$3.51B(+17.1%)
$11.63B(+10.8%)
Dec 1993
$10.50B(+8.6%)
$3.00B(+18.0%)
$10.50B(+4.0%)
Sep 1993
-
$2.54B(-1.1%)
$10.10B(+0.8%)
Jun 1993
-
$2.57B(+8.2%)
$10.02B(+2.0%)
Mar 1993
-
$2.38B(-8.5%)
$9.82B(+1.6%)
Dec 1992
$9.66B(+12.3%)
$2.60B(+5.6%)
$9.66B(+3.1%)
Sep 1992
-
$2.46B(+3.8%)
$9.38B(+3.8%)
Jun 1992
-
$2.37B(+6.8%)
$9.03B(+2.9%)
Mar 1992
-
$2.22B(-3.9%)
$8.78B(+2.0%)
Dec 1991
$8.60B(+12.1%)
$2.31B(+9.3%)
$8.60B(+2.6%)
Sep 1991
-
$2.12B(-0.2%)
$8.39B(+2.5%)
Jun 1991
-
$2.12B(+3.6%)
$8.19B(+2.8%)
Mar 1991
-
$2.05B(-2.4%)
$7.96B(+3.8%)
Dec 1990
$7.67B(+17.1%)
$2.10B(+9.7%)
$7.67B(+4.6%)
Sep 1990
-
$1.91B(+0.8%)
$7.33B(+4.0%)
Jun 1990
-
$1.90B(+8.0%)
$7.05B(+4.7%)
Mar 1990
-
$1.76B(-0.2%)
$6.74B(+2.9%)
Dec 1989
$6.55B(+10.3%)
$1.76B(+7.9%)
$6.55B(+3.6%)
Sep 1989
-
$1.63B(+3.0%)
$6.32B(+2.7%)
Jun 1989
-
$1.59B(+0.9%)
$6.16B(+1.4%)
Mar 1989
-
$1.57B(+2.4%)
$6.07B(+2.3%)
Dec 1988
$5.94B(+17.4%)
$1.53B(+4.4%)
$5.94B(+2.4%)
Sep 1988
-
$1.47B(-2.1%)
$5.80B(+2.9%)
Jun 1988
-
$1.50B(+4.4%)
$5.64B(+4.7%)
Mar 1988
-
$1.44B(+3.0%)
$5.39B(+6.4%)
Dec 1987
$5.06B(+22.6%)
$1.39B(+6.7%)
$5.06B(+5.1%)
Sep 1987
-
$1.31B(+4.6%)
$4.82B(+5.5%)
Jun 1987
-
$1.25B(+12.4%)
$4.56B(+5.7%)
Mar 1987
-
$1.11B(-3.3%)
$4.32B(+4.6%)
Dec 1986
$4.13B(+16.4%)
$1.15B(+9.1%)
$4.13B(+4.9%)
Sep 1986
-
$1.05B(+4.8%)
$3.94B(+5.3%)
Jun 1986
-
$1.00B(+9.1%)
$3.74B(+3.5%)
Mar 1986
-
$921.10M(-3.9%)
$3.61B(+1.8%)
Dec 1985
$3.55B(-0.3%)
$958.00M(+11.9%)
$3.55B(-0.1%)
Sep 1985
-
$855.80M(-2.5%)
$3.55B(-0.1%)
Jun 1985
-
$877.40M(+2.5%)
$3.55B(-0.4%)
Mar 1985
-
$856.30M(-11.0%)
$3.57B(+0.2%)
Dec 1984
$3.56B
$962.00M(+12.1%)
$3.56B(+37.0%)
Sep 1984
-
$857.90M(-3.7%)
$2.60B(+49.3%)
Jun 1984
-
$891.30M(+5.0%)
$1.74B(+105.0%)
Mar 1984
-
$848.60M
$848.60M

FAQ

  • What is Merck & Co annual revenue?
  • What is the all time high annual revenue for Merck & Co?
  • What is Merck & Co annual revenue year-on-year change?
  • What is Merck & Co quarterly revenue?
  • What is the all time high quarterly revenue for Merck & Co?
  • What is Merck & Co quarterly revenue year-on-year change?
  • What is Merck & Co TTM revenue?
  • What is the all time high TTM revenue for Merck & Co?
  • What is Merck & Co TTM revenue year-on-year change?

What is Merck & Co annual revenue?

The current annual revenue of MRK is $64.17B

What is the all time high annual revenue for Merck & Co?

Merck & Co all-time high annual revenue is $64.17B

What is Merck & Co annual revenue year-on-year change?

Over the past year, MRK annual revenue has changed by +$4.05B (+6.74%)

What is Merck & Co quarterly revenue?

The current quarterly revenue of MRK is $15.62B

What is the all time high quarterly revenue for Merck & Co?

Merck & Co all-time high quarterly revenue is $16.66B

What is Merck & Co quarterly revenue year-on-year change?

Over the past year, MRK quarterly revenue has changed by -$1.03B (-6.20%)

What is Merck & Co TTM revenue?

The current TTM revenue of MRK is $64.17B

What is the all time high TTM revenue for Merck & Co?

Merck & Co all-time high TTM revenue is $64.17B

What is Merck & Co TTM revenue year-on-year change?

Over the past year, MRK TTM revenue has changed by +$994.00M (+1.57%)
On this page